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Getting more for their dollar: a comparison of the NHS
with California’s Kaiser Permanente
Richard G A Feachem, Neelam K Sekhri, Karen L White
Abstract
Objective To compare the costs and performance of
the NHS with those of an integrated system for
financing and delivery health services (Kaiser
Permanente) in California.
Methods The adjusted costs of the two systems and
their performance were compared with respect to
inputs, use, access to services, responsiveness, and
limited quality indicators.
Results The per capita costs of the two systems,
adjusted for differences in benefits, special activities,
population characteristics, and the cost environment,
were similar to within 10%. Some aspects of
performance differed. In particular, Kaiser members
experience more comprehensive and convenient
primary care services and much more rapid access to
specialist services and hospital admissions. Age
adjusted rates of use of acute hospital services in
Kaiser were one third of those in the NHS.
Conclusions The widely held beliefs that the NHS is
efficient and that poor performance in certain areas is
largely explained by underinvestment are not
supported by this analysis. Kaiser achieved better
performance at roughly the same cost as the NHS
because of integration throughout the system, efficient
management of hospital use, the benefits of
competition, and greater investment in information
technology.
Introduction
The NHS Plan for 2000 states: “The NHS is effective
and efficient at meeting its goals. The NHS gets more
and fairer health care for every pound invested than
most other health care systems.”1
We examined this claim by comparing the costs
and performance of the NHS with those of a
non›profit health maintenance organisation (Kaiser
Permanente) in California. We compared the NHS and
Kaiser Permanente on a macro level to identify any
large scale differences in efficiency and operational
effectiveness that would be relevant to policy and to
identify topics for further research. We have not exam›
ined the merits of the overall healthcare systems in the
two countries.
Comparisons among health systems are difficult
because of the complexity of the systems and their
contextual specificity. Several authors have made
country›level international comparisons using data
from the Organisation for Economic Cooperation and
Development (OECD)2 or the World Health Organiza›
tion.3 Comparative studies usually conclude that the
United States has high costs and poor population
health outcomes. Beneath this accurate overall
observation, however, lies the multiplicity of different
healthcare systems operating and often competing
within the United States.4
In many ways Kaiser Permanente is like the NHS,
providing a similar range of services for a population
equivalent to that of a small country. Founded in 1945,
it is roughly the same age as the NHS and has had the
same amount of time to evolve and adapt to new
circumstances. Kaiser Foundation Health Plan and
Hospitals are integrated with independent physician
group practices called Permanente Medical Groups.
The health plan is the insurance arm of the
organisation, while the hospitals and medical groups
provide all clinical services. To the public these entities
are seen as one organisation, which is commonly
referred to as Kaiser. Kaiser has 8.2 million members:
6.1 million in California and the remainder in
Colorado, Georgia, Hawaii, Maryland, Ohio, Oregon,
Virginia, Washington, and the District of Columbia.5
We compared Kaiser’s California region with the NHS
because it represents the model most similar to the
NHS. In California, doctors in the Kaiser system (both
primary care and specialist) are shareholders or
partners and salaried employees of the medical
groups, and Kaiser owns and operates most of its own
ambulatory facilities and hospitals. Unlike the NHS,
Kaiser specialists cannot work outside the system.
Methods
We focused on cost and performance. We measured
cost by determining the total operating costs of each
system and by adjusting the benefits offered, special
circumstances not common to both systems, the
relative costs of the medical environment in which the
two systems operate, and the age and socioeconomic
characteristics of the populations served. We measured
performance by comparing inputs, access to services,
responsiveness, and limited quality indicators.
In the 1940s the NHS inherited a large stock of hos›
pitals and facilities whereas Kaiser has had to develop its
infrastructure from scratch. While noting the different
balance between maintenance and capital investment
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that this imposes, we did not take these factors into
account in our analysis. Each system has had over 50
years to manage its capital as it thought appropriate.
We used sources with the broadest range of
comparative data (such as the OECD dataset for
2000).6 Much of the data on the NHS come from the
official NHS website.7 Kaiser data come from the health
plan employer data and information set for 20008 and
directly from Kaiser sources.
In comparing the per capita costs of two systems we
adjusted for age and socioeconomic status. The adjust›
ment for age is straightforward because breakdown of
cost by age is available. The adjustment for socioeco›
nomic group is more difficult because of a lack of age
adjusted comparative data on the healthcare costs of
various socioeconomic groups. We used data from the
Office for National Statistics to adjust for potential
socioeconomic differences.9
In comparing performance between the two
systems, we adjusted only bed day use for age. To adjust
accurately for each performance indicator we would
need detailed case mix data, which were not available.
Also for some of the performance indicators it is not
obvious what specific adjustments would be appropri›
ate even if the data were available.
Results
Costs
Table 1 shows the comparison of costs between the two
systems with details of the adjustments made to arrive
at the final adjusted per capita expenditure.
Package of benefits and special circumstances
Kaiser and the NHS both provide comprehensive
health services, including hospital admission, ambula›
tory and preventive care, accident and emergency,
optometry, subacute care, rehabilitation, and home
health care. For drugs used outside hospital, in the
NHS people under 16 years (or under 25 years in
Wales), over 60 years, and with special exemptions do
not pay for prescriptions (about 80% of all prescription
items) while others pay £6.10 (about $10). Most Kaiser
members pay $5 per prescription. Drugs given to in›
patients are free of charge in both systems
The NHS provides greater coverage than Kaiser in
dental and long term psychiatric care services. For
other services, specifically long term care, precise com›
parison is difficult. Kaiser covers up to 100 days per
year of subacute care, including rehabilitation and
other medical services requiring skilled nursing care. It
also covers home health care, including skilled nursing,
speech and physical therapy, social services for the
housebound, and hospice care. The NHS also covers
medical long term care and home health services.
Non›medical residential care is provided outside the
NHS budget and is not covered by Kaiser. Table 1
shows the amounts deducted from costs for particular
services.
We examined whether either system incurs special
costs or benefits by virtue of its environment that would
considerably bias the cost comparison between the two
systems. For example, the NHS spends over 6% of its
budget on obligations such as education and training,
research and development, statutory and national
bodies, research, European economic area medical
costs, medical, scientific and technical services, grants,
and other miscellaneous services. Equivalent items in
the Kaiser budget account for about 3.5% of expendi›
ture. Kaiser also has considerable administrative costs
such as sales, marketing, high malpractice insurance,
and risk adjusted pricing, which account for about 4%
of its budget.
Private health care
In the United Kingdom about seven million people
(12%) have private medical insurance, making the
private insurance market worth around £2.6b.11
Private insurance serves primarily as a safety valve to
provide more rapid access to specialists and
non›emergency surgeries. Few Kaiser members buy
duplicate insurance.
In addition to private health insurance, out of
pocket spending (that is, paid for directly by the
patient) is important in the United Kingdom, where
about 20% of all private operations are paid for this
way.14 However, as we cannot accurately estimate the
amount of such spending for services that are not cov›
ered by either system (such as alternative therapies,
some cosmetic surgery, and certain drugs) we have not
adjusted for it. We have included costs such as
copayments and direct payments for non›covered
drugs in Kaiser’s overall costs (table 1).
Medical cost environment
After we derived per capita costs for each system we
adjusted for the purchasing power parity of each
system’s currency in the health sector to correct for
underlying price differences in medical inputs—that is,
if the NHS operated in California, or if Kaiser operated
in Kent, what would be their respective per capita costs
adjusted for the relative price of inputs? We can
illustrate why this is necessary by comparing two major
inputs: doctors’ salaries and pharmaceutical costs. For
general practitioners (primary care physicians) Kaiser’s
average starting salaries are 43% higher than average
Table 1 Comparison of costs in the NHS and Kaiser
Category
NHS
(2000/2001)
Kaiser,
California
(2000)
Gross expenditures/revenue £58 500m $14 200m
Less capital depreciation £1 000m $557m
Less profit 0 $668m
Operating expenditures £57 500m $12 975m
Adjustment for differences in benefits and special circumstances:
Dental £1 190m $10m
Long term psychiatric care £3 250m Not covered
Special circumstances £3 587m $1 065m
Supplementary private health insurance £2 630m 0
Net expenditure after adjustments £52 103m $11 900m
Per capita expenditure (59.5 million people for
NHS; 6.1 million people for Kaiser)
£876 $1951
Conversion to dollars* $1402 $1951
Adjustment for PPP (1.52)† $2130 $1951
Adjustment for age (decreases NHS costs by
12.2%) and socioeconomic group (decreases
NHS costs 5%)
$1764 $1951
Final adjusted per capita expenditure $1764 $1951
Sources: Lakin,9 Department of Health,10 Laing & Buisson,11 OANDA,12 World
Bank,13 and unpublished data from Kaiser.
*Uses average exchange rate for the 1990s of 1.6.
†Purchasing power parity: rate of currency conversion that equalises
purchasing power in health sector of different currencies.
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NHS salaries. For consultants (specialists) starting sala›
ries are 115% higher in Kaiser (Kaiser, unpublished
data).15 A standard basket of pharmaceuticals has been
variously estimated to cost 20%,16 55%,17 and 60%18
more in the United States than in the United Kingdom.
Overall, prices in the US health sector have been
estimated to be 52% higher by the World Bank13 and
56% higher by the Organisation for Economic
Cooperation and Development6 than in the UK sector.
We used the lower World Bank ratio of 1.52 to adjust
for purchasing power parity in table 1.
Populations served
One of the most difficult tasks in comparing health sys›
tems is to determine whether the populations served
by the two systems are similar. It is impossible to
account for every variable that distinguishes one popu›
lation from another. We adjusted for age and socioeco›
nomic status, both of which may significantly affect
healthcare costs.
The NHS serves the entire population of the
United Kingdom. Kaiser serves its members, 93% of
whom become members through health plans
sponsored by employers or the government (Kaiser,
unpublished data). Kaiser members who join through
employer schemes or through government pro›
grammes for indigent and elderly people cannot be
rejected because of previous illness. Membership
cannot be withdrawn if a member becomes chronically
or seriously ill.
Sixteen per cent of UK citizens and 10% of Kaiser
members are aged over 65 years. California is a young
state (11% aged > 65 years) and the United States is a
young country (13% > 65 years) compared with the
United Kingdom (Kaiser, unpublished data).19 20 In the
United States people over 65 are provided health cov›
erage through Medicare, a federal programme for eld›
erly people. They can choose to receive services
through managed care organisations or on a fee for
service basis. Many select the Kaiser system because of
the comprehensive package of services it offers. Table 2
shows the age distributions of the two populations. We
have used age specific per capita costs10 and adjusted
NHS costs for what they would be if the United King›
dom had Kaiser’s age distribution. This results in a
12.2% decrease in NHS per capita costs (table 1).
The NHS covers all socioeconomic groups. Kaiser
members tend to come from middle to mid›lower
socioeconomic groups because wealthier families
mostly opt for more flexible and more expensive
healthcare options. By US standards, Kaiser is regarded
as a “working class” system.
Few Kaiser members are very poor. About 3.5% are
in Medi›Cal (Kaiser, unpublished data), the govern›
ment financed programme for indigent and very low
income families in California. About 15% of Califor›
nia’s population are in Medi›Cal. Contrary to common
perception, however, people in Medi›Cal cost less per
capita than the general population because they tend
to be younger (71% < 35 years v 53% < 35 years for
the general California population) and are lower users
of health care.20 21 Medi›Cal’s total per capita costs in
1998 were $2011 compared with $3370 for overall per
capita healthcare costs in California.21 Although Kaiser
does not serve a representative proportion of Medi›Cal
members, those who enrol receive full benefits, which
in some cases are more comprehensive than for com›
mercial members.
By definition all Kaiser members are insured.
About 24% of California’s population is uninsured.22
Kaiser does, however, provide care to non›members,
who make up 5% of all admissions to Kaiser
community hospitals. Many of these patients are unin›
sured. In examining the healthcare costs of uninsured
people, it is important to note that almost none are
aged over 65 years because they are eligible for Medi›
care. About 81% of uninsured people are employees
and their families, and 62% are aged under 40 years.22
It can therefore be argued that the lower represen›
tation of poor and uninsured people among Kaiser’s
members does not give Kaiser a cost advantage relative
to a system that covers the entire population. However,
we wanted to ensure that we accounted for any possible
bias arising from the NHS having to provide care to all
socioeconomic groups. According to the Office for
National Statistics, NHS overall per capita costs would
be about 5% lower if it did not provide services to the
poorest half of all the UK population under the age of
65 years.9 We therefore adjusted per capita costs for the
NHS down by 5% (table 1). We have not adjusted for
potential socioeconomic differences of people above
retirement age because a representative portion of
Kaiser members are retired (aged over 65 years) and
are insured through Medicare.
After all adjustments the NHS ($1764) and Kaiser
($1951) costs per capita were similar.
Performance
We compared the NHS and Kaiser on selected
measures of performance from preventive services to
highly specialised interventions.
Input and use
Primary care services are organised differently in the
two systems. In the NHS, primary care is provided by
general practitioners, often with only a modest level of
support from other healthcare providers. In general,
three full time general practitioners use one full time
equivalent practice nurse. This nurse may perform
only basic medical care and is responsible for adminis›
trative functions as well, though increasing numbers of
NHS practice nurses are gaining additional skills. Most
general practices have a pharmacy close by, and about
a quarter have pharmacies on site (NHS, unpublished
data). Physiotherapy and mental health services are
often available on site for a limited time during the
week (table 3).
Table 2 Age distribution of members of Kaiser California and UK
population, 2000
Age (years) Kaiser (%) UK (%) NHS Costs per capita* (£)
0›4 6.0 6.0 504
5›15 15.0 14.3 131
16›44 43.1 40.8 264
45›64 25.7 23.4 363
65›74 6.3 8.2 696
75›84 3.2 5.4 1246
>85 0.7 1.9 1993
Sources: Department of Health,10 Office for National Statistics,19 and
unpublished Kaiser data.
*NHS per capita costs for the Hospital and Community Health Services
component of the NHS budget.
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In Kaiser, primary care physicians include doctors
accredited in family medicine, internal medicine,
paediatrics, and obstetrics and gynaecology. As a result
physicians in the primary care setting are able to
perform more complicated procedures, freeing up
referral specialists to focus on more complex cases.
These primary care doctors work in multi›specialty
centres that employ between five and 40 doctors and
are supported by physician assistants and nurse practi›
tioners, who have their own lists of patients and are
able to conduct clinical examinations, make diagnoses,
and prescribe some medications. These “physician
extenders” increase the number of available clinical
staff by almost two thirds. Laboratory, radiology, and
pharmacy services are usually available on site. Some
centres also have physiotherapy and mental health
services, while others include various specialist services
in the same building. In addition, these facilities are
open in the evenings and weekends for urgent visits
(table 3).
Specialists are categorised somewhat differently
across the two systems. For example, the United King›
dom has many hospital based “general medicine” spe›
cialists. These are most similar to “hospitalists” within
the Kaiser system, though some primary care
physicians also follow their patients in the hospital set›
ting. It is clear from table 3, however, that Kaiser has
considerably more specialists per 100 000 population
than the NHS, even when registrars are included in the
NHS specialist numbers. For example, Kaiser has twice
the concentration of obstetricians›gynaecologists and
three times the concentration of cardiologists than in
the NHS. This results in much shorter waiting times for
specialist referrals and surgical procedures.
There were nearly four times the number of acute
bed days per 1000 population per year in the NHS
than in Kaiser (table 3), reflecting large differences in
the management of admissions and lengths of stay. The
Kaiser average of 270 acute bed days per 1000 popula›
tion is made up of 193 days for those aged under 65
years and 1031 days for those aged over 65 years (Kai›
ser, unpublished data). The figure for the NHS of 1000
per 1000 population is for all age groups.6 If Kaiser had
the age distribution of the United Kingdom its acute
bed days would be 327, still only one third of the NHS
figure. Kaiser acute bed days are low by US standards
but not unique.26
Access and responsiveness
The NHS Plan (2000) states: “The public’s top concern
about the NHS is waiting for treatment. Waiting to see
a GP, waiting to be seen in a casualty department, wait›
ing to get into hospital and, sometimes, waiting to get
out of hospital.”1 On 28 February 2001, 45 500 people
in England alone had been waiting for more than one
year for admission to hospital.27
Table 4 shows various comparisons of responsive›
ness to patients. Access to primary care is similar in
both systems, though primary care physicians in Kaiser
spend longer with each patient. More time spent with
Table 3 Comparison of inputs and use in NHS and Kaiser, 2000
Inputs NHS
Kaiser,
California
Specialists per 100 000 people
Pediatricians 4.9* 12.3
Obstetricians›gynaecologists 4.1* 8.3
Oncologists 0.9* 1.7
Radiologists 4.3* 6.0
Cardiologists 0.8† 2.4
Primary care facilities
Percentage of primary care physicians in single
handed practices
9%‡ 0%
Average No of primary care physicians per office 3{5‡ 20›40
Percentage of primary care physicians with
laboratory, imaging, or pharmacy on site
25%›pharmacy
(few with other
services)
>95%
Percentage of primary care physicians
connected to clinical IT system
100% by 2002 >95% today
Use
Average acute length of stay (days) 5.0§ 3.9
Acute bed days per 1000 per year 1000 270
Sources: NHS plan,1 OECD,6 HEDIS,8 unpublished Kaiser data, Department of
Health,23 24 Office of Health Economics.25
*1999 Includes registrars as well as consultants for England.
†1998 Consultants for England.
‡1998 data.
§1996 latest OECD data.
¶1997 latest OECD data.
Table 4 Comparing responsiveness of NHS and Kaiser to consumers, 2001
Measure NHS Kaiser, California
Primary care
Time to see a primary care doctor 2001: average 3 days; <48 hour by 2004 Urgent: <24 hours; routine: 80% <7 days
Telephone helpline and associated services NHS Direct helpline available. By 2004, NHS Direct
will provide one stop gateway to advice,
appointments, and out of hours care
24 hour hotline available for advice and appointments.
Appointments can also be made on line
Repeat prescription available without calling or
visiting a doctor
Available nationwide by 2004 Available today
Time spent with primary care doctor 8.8 minutes* Medical: 20 minutes; obstetrics/gynaecology:
15 minutes; paediatrics: 10 minutes
Specialist referral
Waiting time to see specialist 2001: 36% <4 weeks, 20% >13 weeks, 4% >6
months; by 2005, average 5 weeks and maximum 3
months
2001: 80% <2 weeks
Waiting time for inpatient treatment or surgery 2001: 41% <13 weeks, 33% >5 months, 7% >12
months; by 2005: average 7 weeks and maximum 6
months
2001: 90% <13 weeks
Patient convenience
Patients’ ability to book appointments and
admissions to suit own schedule
2001: minimal; by 2005: universal To a high degree
Availability of translation services By 2003: available by telephone Available on site and by telephone
Sources: NHS Plan,1 Office of Health Economics,25 Department of Health,28 and unpublished Kaiser data.
*1992/93 survey.
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patients is associated with improved patient satisfac›
tion and diagnostic accuracy.29 Table 4 also shows how
the Kaiser system provides much more rapid access to
specialists and hospitals than the NHS. For example, in
the NHS 80% of patients referred to a consultant are
seen within 13 weeks whereas in Kaiser 80% are seen
within two weeks. One third of NHS patients wait more
than five months for hospital admission whereas in
Kaiser 90% are admitted within three months.
Quality
Comparisons of Kaiser with other healthcare provid›
ers in California and the United States have found Kai›
ser’s quality and outcomes to be average or better.30 31
Clinical outcomes for certain diagnoses in the United
States are better than in the United Kingdom. For
example, the five year survival for men with lung
cancer in the United States is twice that in the United
Kingdom, and the five year survival for woman with
breast cancer is 24% higher.32
Table 5 shows that rates of childhood immunisation
and screening for cancer in women are similar, as are
rates of heart transplantation, though Kaiser undertakes
78% more kidney transplants. Kaiser patients are far
more likely to receive appropriate treatment and
intervention for diabetes and heart disease.
It is difficult to compare population health
outcomes within the two systems. California’s popula›
tion health outcomes, however, are the same as those
in the United Kingdom: life expectancy in men is 75
years and in women is 80 years, and the infant
mortality is six per 1000 live births.6 37 Kaiser members
have similar population health statistics to the Califor›
nia population (Kaiser, unpublished data) and there›
fore to the UK population.
Discussion
In this comparative study of the NHS and Kaiser we
have shown that though per capita costs of the two sys›
tems are similar there are large differences in some
measures of performance, particularly in access to
specialists, waiting times, and other aspects of
responsiveness to patients. The validity of our findings
could be criticised in four main ways.
Does Kaiser provide as comprehensive a service as the
NHS?—Eight million Kaiser members receive all their
health care in the Kaiser system, and the services
offered by the two systems are surprisingly similar.
Where there are differences, for example in long term
psychiatric care and dental care, we have adjusted the
NHS per capita costs.
Does Kaiser cover a healthier or richer population than
the NHS?—Few Kaiser members are rich or very poor.
We have discussed the likely affects of this, which we
believe to be neutral. To avoid any socioeconomic bias,
however, we adjusted costs by an amount that would be
equivalent to the NHS not covering the poorest half of
the UK population aged under 65 years. We believe
that this is an over›adjustment. We did not adjust for
those aged over 65 years as elderly people have univer›
sal health coverage through Medicare and are
appropriately represented in the Kaiser membership.
Are Californians healthier than UK citizens?—There is
no basis for this belief. The life expectancies in Califor›
nia and the United Kingdom are identical. Both popu›
lations live in temperate climates, share similar risk
factors, and have many occupational and cultural simi›
larities. If there are differences in the rates of specific
diseases these can be partly attributed to the relative
effectiveness of the healthcare systems.
Can Kaiser exclude or terminate membership of sick
people?—About 93% of Kaiser members join through
groups or government programmes such as Medicare,
where all participants and family members are
accepted regardless of health and history. Further›
more, according to California state law, health plans or
insurers cannot terminate membership because of
illness.38
A major potential influence on costs for which we
have not adjusted is patient and medical culture. Com›
pared with the United Kingdom there is ample
evidence that US patients are more demanding and
that US doctors are more interventionist. Adjustment
Table 5 Comparison of quality in the NHS and Kaiser, 1999
Measure NHS Kaiser, California
Vaccination
Children who received various immunisations by age 2 years DTP=95%; MMR=88%; Hib=94% DTP=91%*; polio=93%*; MMR=94%*;
Hib=91%*; hepatitis B=86%*; chicken pox 83%*
Cancer screening
Breast 69% of women aged 50›64 years had
mammogram in past 3 years†
78% of women aged 52›69 years had
>1 mammograms in past 2 years*
Cervical 84% women aged 25›64 years screened at
least once in past 5 years‡
80% of women aged 21›64 years screened at
least once in past 3 years*
Diabetic care
People with diabetes who received annual retinal examination 60% 70% for <65 years; 80% for >65 years
Cardiovascular care
Patients with acute myocardial infarction who received â blockers 42%‡ 93%
Coronary revascularisation procedures per 100 000:
Angioplasty 38§ 116
Bypass graft 47§ 127
Transplantation per 100 000
Heart 0.5 0.5
Kidney 2.7 4.8
Sources: OECD,6 HEDIS,8 Department of Health,23 Barakat,33 NHS,34 CCHRI,35 Ayanian and Quinn,36 and unpublished Kaiser data.
*Data from Kaiser US (not California).
†2000, England.
‡1997, England.
§1998, England.
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for these differences would lower Kaiser costs relative
to the United Kingdom and make our comparison
more robust.
Findings to promote further research
The comparison of bed days is the most striking differ›
ence between Kaiser and the NHS. This difference
explains, to a large extent, how Kaiser can provide
more and better paid specialists and perform more
medical interventions with much shorter waiting times
than the NHS for roughly the same per capita cost.
Hospital bed days are the most expensive component
of any health system. Inefficient use of beds leads to
long waiting times. Limiting the number of beds
permits large sums of capital to be freed up to fund
improved information technology, comprehensive and
convenient primary care facilities, ambulatory surgery
centres, and other facilities. Also, scarce clinical
resources (such as physicians and nurses) can be used
more effectively for prevention, chronic disease
management, home care services, and support services
to keep people healthy and functioning independently.
If the NHS had Kaiser’s acute bed day average
(adjusted for the higher proportion of the population
aged over 65 years) it could save up to 40 million hos›
pital days or £10bn per year (assuming a cost of £250
per bed day). These savings represent more than 17%
of the NHS budget and could be spent on more and
better paid staff, better equipment and facilities, and
improved information technology. Kaiser, like most US
health plans, focuses much attention and many
resources on monitoring admissions, reducing lengths
of stay, creating disease management programmes for
chronic conditions, and opening doctors offices in the
evenings and weekends to reduce the use of
emergency rooms for non›emergency care.
A second striking difference is in the availability of
specialists. Kaiser has fewer specialists per 100 000
population than the US, it provides two to three times
the concentration of oncologists, paediatricians, obste›
tricians, and cardiologists than the NHS. Given the age
distribution of the United Kingdom and the higher
disease burden of elderly people the NHS would have
even lower concentrations of specialists per thousand
population on an age adjusted basis than Kaiser.
Some of the differences in numbers of specialists
reflect variations in medical practice between the two
countries, which, some would argue, do not adversely
affect quality of care. For example, in the United States
every patient with cancer is managed by an oncologist,
and in the Kaiser system obstetricians, rather than
midwives or family practitioners, deliver babies. In
other cases, however, the shortage of specialists
increases waiting times for patients in the NHS and
adversely affects quality of care.
As a direct result of the two factors above, large dif›
ferences in access to care are experienced between
NHS and Kaiser patients. Waiting times to see a
specialist are over six times as long in the NHS, and
even by 2005 the NHS will not come close to Kaiser’s
access standards. Waiting times for non›emergency
admissions are over twice as long and again will not
meet Kaiser’s average by 2005.
Conclusions
Managed care, of which the Kaiser system is one mani›
festation, is now the norm in the United States,
covering 92% of all those with health insurance spon›
sored by an employer.39 Despite this, managed care has
recently been criticised by the public, healthcare
professionals, and politicians. Indeed, managed care
companies rate above airlines, drug companies, and oil
companies and alongside the tobacco industry in the
degree of public disapproval.4 Most members of health
maintenance organisations, however, report satisfac›
tion with their own health plans.40
Our overall conclusion is that healthcare costs per
capita in Kaiser and the NHS are similar to within 10%
and that Kaiser’s performance is considerably better in
certain respects, particularly access to specialist
diagnosis and treatment and hospital waiting times. We
think that there may be several explanations for why
this is so.
Achieving real integration—Kaiser has achieved real
integration through partnerships between physicians
and administration and can exercise control and
accountability across all components of the healthcare
system. This allows it to manage patients in the most
appropriate setting, implement disease management
programmes for chronic conditions, and make
trade›offs in expenditures based on appropriateness
and cost effectiveness rather than artificial budget
categories.
Treating patients at the most cost effective level of care—
Kaiser members spend one third of the time in hospi›
tal compared with NHS patients. There is ample
evidence that reduced length of hospital stay does no
harm41 and, in view of the risks of staying in hospital,
may be beneficial.42 As a direct result of its integration
Kaiser is effective in controlling admission rates and
lengths of stay and therefore has fewer acute bed days
per unit of population.
Benefits of competition and choice—Bulk purchasers of
health care in the United States, such as federal and
state government, large employers, and consortia of
small employers, can and do bargain hard on price and
quality. Individual members in the United States
(whether enrolled through their employer, Medicaid,
or Medicare) are offered a choice of health plans and
can move each year without penalty. Satisfaction and
loyalty of members therefore matter. Kaiser members
are a representative subset of the US population and
particularly the Californian population. This popula›
tion has high expectations and will not settle for less.
Information technology—The more advanced parts of
the Kaiser system have sophisticated and efficient
information technology systems that reduce adminis›
trative time, particularly clinician’s time spent taking
medical histories, dictating letters, and locating patient
records. Kaiser plans to invest a further $2b over the
next five years (2% of total budget) to extend this virtu›
ally paperless patient care system to 423 outpatient
centres and over 11 000 clinicians.43 The NHS plans to
spend about 0.5% of its budget over the next few years
on development of information technology and hopes
to have all general practitioners and specialists
connected to NHSNet by 2005.1
Of these four overall factors that may explain
Kaiser’s performance, the NHS is already pursuing
reforms in integration and information technology
and can continue to do so with no major restructuring.
There is also scope within the current structure of the
NHS for more efficient use of hospitals, and further
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analysis of Kaiser operations and methods may prove
beneficial. Competition, however, clearly has more
radical implications for the NHS. Creating a truly com›
petitive environment would entail ending or seriously
eroding the current monopsony power of the NHS.
This would have far reaching consequences requiring
greater thought to avoid potential negative effects.
Though our findings are not exhaustive they point to
the value of comparing healthcare systems. We hope
that they will encourage further analysis and policy
debate.
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What is already known on this topic
Comparisons of healthcare systems in different countries have to be
undertaken with great care but can be instructive
The overall healthcare system in the United States is more expensive
than the NHS and population health outcomes are no better
The US healthcare system comprises many discrete and unique
subsystems, including the health maintenance organisations
What this paper adds
An integrated, non›profit health maintenance organisation in
California (Kaiser Permanente), with over six million members, costs
about the same as the NHS but performs considerably better
Kaiser’s superior performance is mainly in prompt and appropriate
diagnosis and treatment
These findings challenge the widely held view that the NHS is efficient
and that its inadequacies are mainly due to underinvestment
Correction
Collaborative meta›analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and stroke
in high risk patients
In this paper by the Antithrombotic Trialists’ Collaboration
(12 January, p 71) a missing two letters make a world of dif›
ference to the meaning of the last sentence. The very last
word should be “inappropriate” (rather than “appropriate”),
so that the sentence reads: “For most healthy individuals,
however, for whom the risk of a vascular event is likely to be
substantially less than 1% a year, daily aspirin may well be
inappropriate.” We apologise for this error.
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Commentary: Funding is not the only factor
Jennifer Dixon
If there ever was a time when there was a political
imperative in the United Kingdom to improve public
services, this is it. In the case of the NHS, the reason for
suboptimal performance has most frequently (and
conveniently) been thought of as due to chronic lack of
funding. Discussions on how to improve services have
therefore usually centred on levels and methods of
financing the service. Though funding is obviously
important, what other factors are also crucial?
Feachem et al have presented an interesting
comparison of the costs and performance of two health
systems—Kaiser Permanente and the NHS. Any study of
this type stands or falls by the accuracy of the compari›
sons, in particular in comparing like with like across
both systems. The authors go some way in this respect,
with adjustment for numerous factors. The two chief
adjustments made in the comparison of costs—to ensure
that the age, socioeconomic status, and illness levels of
the populations served are comparable and to ensure
that the benefits offered in both systems are similar—are
broadly addressed and discussed by the authors, includ›
ing their limitations. It is, of course, possible to challenge
the details of such adjustments and the assumptions
(and data) on which they are based. The main question
is, would such debate change the broad findings—similar
per capita costs between the two systems yet some clear
differences in performance? I suspect not.
Such findings are important for debate, in particular
to shift thinking from ever sterile discussion over what is
the “right” level of funding or method of financing for
the NHS to thinking about improving performance. But
to be useful as a starting point for shaping policy for the
NHS, clearly much more work would need to be done to
compare the two systems in a more detailed way and to
examine further the arguments and data that have been
used in the paper. If the broad messages stand as
presented, a fundamental question to ask would be why
Kaiser can apparently provide care to a higher perform›
ance at similar cost? The authors rather modestly
suggest four main reasons: better integration of care;
treatment of patients at the most cost effective level of
care; the benefits of competition and choice; and better
information technology. But the truth could be a far big›
ger set of factors. Specific factors could include the form
of organisation, the level and type of financial incentives
operating, the extent that power and decision making
concentrates at the top of the organisation, and the
number and training of staff. Other and possibly more
important factors could include the type of leadership,
the quality of management, the ethos of service in the
organisation, how staff are valued and promoted, and
the extent of party political involvement in manage›
ment. We simply do not know enough, and the science
of inquiry into these areas is hardly even in its infancy.
Meantime in the NHS, time is short and so politicians
tend to fall back on to fad or ideology to shape the serv›
ice rather than science (such as it is) or even experience.
If I were in their shoes, I would pore over Feachem’s
paper, encourage a few seasoned chief executives in the
NHS with a good track record to go to study Kaiser, take
time to learn the lessons, and genuinely follow the
maxim “what counts is what works.”
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Commentary: Same price, better care
Donald M Berwick
A conviction of scarcity abounds in the NHS. To
question that claim is perilous, but the paper by
Feachem et al runs the risk. Their conclusions, if
believed, are blockbusters. They find that the per capita
costs in Kaiser and the NHS “are similar to within 10%”
and that Kaiser’s performance in several important
areas, including key preventive practices and the
strategically crucial dimension of access to care, is
“significantly better.”
Should we believe it? The adjustments needed to
allow an “apples to apples” comparison are tough, but
the methods in this paper are good enough to sustain
the basic point. Most crucially, the paper is believable
primarily because of one key difference between the
systems that can almost alone explain a great deal of
what else the authors find—namely, that the NHS today
uses about three times as many days of hospital admis›
sion per capita than the best American care systems do,
with age adjusted figures of 1000 bed days per 1000
population compared with Kaiser’s 327.
This leads to the question of why Kaiser patients
get “more for their money” than NHS patients do. The
key answer is that the systems differ in their capacity to
configure care according to the needs of the patient
throughout an episode of illness or, in the case of
chronic illness, the patient’s life. Kaiser integrates care
much more reliably than the NHS does.
Kaiser achieves both its favourable cost structure
and its superior performance largely through its enor›
mous capacity to help to manage a constructive patient
journey from the outpatient arena to hospital and spe›
cialty services and back. This vision—one integrated
patient “journey”—is the right one for the NHS to seek,
and yet, strikingly and paradoxically, the healthcare
system in the world best positioned to manage care
often does not. The results include an unnecessarily
log jammed hospital sector, long waits, and a sense of
scarcity.
This could change. The NHS could become the
integrated care system it should be. Well designed care
for populations must always align the concerns of hos›
pitals and specialists with the objective of treating
patients at the appropriate level of care. Hospitals must
regard an unneeded day of stay in hospital as a defect,
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and specialists must understand that their primary job
is to include participation in coordinated care, not just
to render care. The challenge goes far beyond mere
cooperation between primary care clinicians, hospitals,
and hospital based specialists. It requires development
and implementation of a systemic vision of the
configuration and resources needed for a care system
at the population level. Rates of hospital use are a
litmus test for integration of care.
I suggest that a social experiment would help the
NHS. Let one area with one or two million citizens,
under the guidance of a strategic health authority and
with the support of the primary care trusts and hospi›
tal trusts within it, undertake a bold, four year effort to
redesign patient flow and resources to aim for the
Kaiser system benchmarks. With the same resources as
at present, plus its share of the government’s new
investment, let that area aim for a 50% reduction in
hospital bed day use per capita as a sentinel effect of
integrated care, reallocating capital and operating
funds as needed to achieve that from hospital care to
outpatient specialty care, supportive information tech›
nology, care coordination processes, and enhance›
ments of support to the primary care clinicians. Let its
performance goals include dramatic reductions in
waiting times for necessary hospital beds and specialty
services. Let it tolerate no harm at all accruing to
patients as it pursues this aim. On the contrary, let it
promise its patients a level of continuity and safety in
their care never before experienced.
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Commentary: Competition made them do it
Alain C Enthoven
One can always argue over details in such an analysis,
but I believe Feachem et al got it about right: Kaiser Per›
manente produces more value for the resources used
than the NHS does. The reduction of two thirds in hos›
pital use is particularly striking, as is the greatly
increased availability and accessibility of specialists. And
I think the authors got the basic explanatory factors
right. British people ought to think about how and why
Kaiser does it.
Kaiser exists in an extremely competitive market.
Every member can change health plans once a year,
and in California they have good alternatives. The pro›
gramme attracts the loyalty, commitment, and respon›
sible participation of its physicians. Primary care
physicians are partners of the specialists, and they work
together in the same facilities. As Feachem et al
observe, the system is an integrated whole.
How can the United Kingdom obtain the
advantages of a more efficient healthcare system? As
secretary of state Alan Milburn has apparently and
recently come to realise, consumer choice and compe›
tition are absolutely critical.1 2 One possible way
forward would be to create a “wide open market” for
hospital services in which private hospitals in Britain
and European hospitals can compete to serve NHS
patients. (This can be contrasted with the compara›
tively timid “internal market” that envisioned competi›
tion mainly among NHS hospitals.3 4) Next, primary
care trusts should be helped to develop the
information, skills, and methods to purchase services
from private sector and European hospitals. The NHS
should seek to become a reliable business partner to
attract investment to care for NHS patients. The
present strong bias in favour of NHS hospitals, with
others used only as a last resort, should be removed.
Primary care trusts would still be in monopoly
positions with little or no incentive to improve services
or allocation of resources. In large metropolitan areas
patients should be given the choice of primary care
trusts, with the ability to take their risk adjusted capita›
tion payment with them to the trust of their choice.
Moreover, trusts could hire their own secondary care
specialists, if they found it economical, letting them
grow gradually into multispecialty group practices.
For a truly efficient competitive market to evolve the
government must be sure that key foundations are being
built.5 As Margaret Thatcher said, “Money must follow
patients” so that hospitals that succeed in attracting
more patients don’t get more work without the
appropriate increase in resources. The corollary is that
less money flows to hospitals that do not attract patients.
Real competition can be brutal. Through educating the
public the government must create political space for
the market to work. It must press forward aggressively
with its information agenda so that risk adjusted
outcomes, waiting times, and data on patient satisfaction
are available to patients and referring general practition›
ers. (Similar information requirements should apply to
private sector and European hospitals.)
Hospitals need to do a better job of understanding
hospital costs. Primary care trusts must have complete
freedom to purchase from the best suppliers (where
“best” depends on the preferences and characteristics
of each patient). The government should encourage a
competitive hospital sector and block, or even reverse,
mergers that substantially reduce competition. The
government needs to operate a competitive capital
market for NHS hospitals in which capital follows
patients. Finally, there needs to be a common
language and currency for buying and selling the
many complex services that go into health care so that
comparisons are easy to make and transaction costs
kept low.
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